Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer

The lack of an effective medical treatment for adrenocortical carcinoma (ACC) has prompted the search for better treatment protocols for ACC neoplasms. Sorafenib, a tyrosine kinase inhibitor has exhibited effectiveness in the treatment of different human tumors. Therefore, the aim of this study was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Endocrinol (Lausanne)
Main Authors: Cerquetti, Lidia, Bucci, Barbara, Raffa, Salvatore, Amendola, Donatella, Maggio, Roberta, Lardo, Pina, Petrangeli, Elisa, Torrisi, Maria Rosaria, Toscano, Vincenzo, Pugliese, Giuseppe, Stigliano, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Endocrinology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8183165/
https://ncbi.nlm.nih.gov/pubmed/34108938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.667798
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados